Within the 32-gene signature, genes upregulated in the pSP include previously proposed pancreatic CSC markers (CXCR4, CD133) or play a role in multidrug resistance (ABCB1) and in pathways important in tumorigenesis and tumor progression (see Table S4). The gene discussed is CXCR4; the disease is neoplasm.